--- title: 'Manager, Commercial Strategy Analytics at Entrada Therapeutics' canonical: 'https://feeny.ai/job/manager-commercial-strategy-analytics-entrada-therapeutics-boston-93h032mf0742' type: 'job' last_seen: '2026-10-18' --- # Manager, Commercial Strategy Analytics at Entrada Therapeutics - **Company:** Entrada Therapeutics - **Location:** Boston, MA - **Posted:** 2026-10-16 - **Last confirmed live:** 2026-10-18 - **Apply:** https://job-boards.greenhouse.io/entradatherapeutics/jobs/5267340007 ## Job description The Organization What's happening at Entrada Therapeutics? Entrada is a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. Through proprietary and versatile approaches, Entrada is advancing a robust development portfolio of genetic medicines for the potential treatment of neuromuscular and inherited retinal diseases, among others. Our lead oligonucleotide programs are in development for the potential treatment of people living with Duchenne muscular dystrophy (DMD) who are exon 44, 45, 50 and 51 skipping amenable. Entrada has partnered with Vertex Pharmaceuticals to develop a clinical-stage program, VX-670, for myotonic dystrophy type 1 (DM1). 2026 represents a catalyst-rich period for Entrada. We expect multiple clinical data readouts as we advance several DMD programs across the U.K., EU, and U.S. By year-end 2026, we anticipate four clinical-stage programs in our DMD franchise (ENTR-601-44, ENTR-601-45, ENTR-601-50, and ENTR-601-51). These programs are complemented by the ongoing clinical progress of our DM1 collaboration with Vertex (VX-670). We are a tight-knit team of experts and leaders in both therapeutic development and rare diseases and are excited to grow and attract colleagues who are ready to join a high-energy, dedicated team that likes to get things done and dramatically improve the lives of patients and their families. The Perfect Addition to Our Team You are interested in working at the intersection of life sciences and business. You want to join a high-growth biotech company in a business strategy role to support the team by synthesizing and communicating strategic insights as we prepare for commercial launch. You bring to the table a combination of an inquisitive spirit, critical thinking, and deep analytical skills and you love performing data-driven analyses to generate strategic insights. You are comfortable working in ambiguity and thrive in fast paced situations. You look forward to working with and learning from leaders across the organization in a high impact role. The Opportunity This position will report to the Director of Business Development and Corporate Strategy and support a variety of projects for the early commercial strategy team. Example workstreams include partnership and ownership across competitive intelligence, market research, and forecasting analysis. You’ll conduct primary and secondary market research to gather data to drive key insights and analyses to support Entrada’s pre-commercial strategy. You’ll be expected to be a key member of the team by distilling market insights and data in a timely fashion to generate strategic takeaways and recommendations for key decision makers across the organization. ## Responsibilities - Support development of asset-level and portfolio-level pre-commercial or commercial readiness analyses across target indications and geographies. - Conduct market sizing, epidemiology, competitive landscape, and pricing & reimbursement analyses. - Build and maintain revenue forecast models incorporating insights from the evolving clinical, regulatory, and market landscape. - Support continued development of existing initiatives across the corporate strategy team. - Gather and capture market data to support data-driven analyses, generate strategic insights, and communicate findings in an efficient manner. The Necessities At Entrada, our passion for science, our devotion to patients and our values drives our behavior: - Humanity - We genuinely care about patients and about one another. - Tenacity - We are relentless and persistent in the pursuit of developing therapies for patients. - Creativity - We are creative problem solvers. - Collaboration - We are more than the sum of our parts. - Curiosity - We have a growth mindset and push conventional thought and theory. To thrive on our team, you will need to come with: - Bachelor’s degree in a life sciences discipline required; PhD, MBA or other advanced degree strongly preferred. - 5+ years of relevant experience, preferably in an analytical role such as market research, equity research, life sciences consulting, commercial analytics, or prior experience in biotech/pharma. - Direct experience synthesizing and communicating competitive insights from drug development programs and/or companies. - Exceptional analytical skills combined with a broad understanding of the life sciences business and R&D process. - Excellent communication skills engaging with external experts and internal stakeholders to gather insights and feedback. - Experience building and interpreting financial models and communicating modeling outputs to support strategic decision making. - Familiarity with the rare disease space and a desire to work in a fast-paced, innovative, and collaborative environment. - Ability to be a team player with a can-do attitude and a willingness to embrace new challenges and the flexibility to adjust course, based on new findings and team inputs. This is a hybrid position, with the requirement for candidates to be based out of Entrada Therapeutics headquarters office 2-3 days per week in Boston, MA. What We Offer: Meaningful Work, Fair Rewards, and Real Support At Entrada Therapeutics, we understand that compensation and total rewards are a major consideration when exploring a new opportunity. We believe in transparency and equity and are committed to sharing salary ranges for every position, along with insight into our compensation philosophy, in accordance with certain state requirements in the United States and fostering a fair and open environment at the onset. But we also know it is more than just pay. When you join Entrada, you’ll be part of a mission-driven team with access to comprehensive health, dental and vision coverage; life and disability insurance; with a 401(k) match. We pride ourselves on offering competitive benefits that empower our employees and reflect the value of their contributions – offering paid, gender-inclusive parental leave, holistic support for your health and well-being, education reimbursement, discretionary time off and commuting benefits aligned to your working model. If you find yourself working from our office in Boston’s Seaport District, this puts you steps away from some of the best the city has to offer. At Entrada, our approach to compensation is grounded in transparency, equity, and performance, recognizing the unique contributions each person brings. We believe meaningful work deserves meaningful reward, and view compensation as one way to show appreciation for the collaboration, curiosity, and commitment that drive our mission forward. The salary for this opportunity ranges from $126,800 - $166,500. The final base compensation offered will depend on several considerations which include but may not be limited to a candidate’s skills, competencies, experience and other job-related factors permitted by law. The final salary offered may fall outside of this range. #LI-Hybrid #LI-JF1 ## Equal Opportunity Employer Entrada Therapeutics is an equal opportunity employer. Qualified candidates will receive consideration for employment without regard to race, color, religion, national origin, gender, sexual orientation, gender identity or expression, age, mental or physical disability, and genetic information, marital status, citizenship status, military status, protected veteran status or any other category protected by law. Third Party Staffing Agencies Entrada does not accept unsolicited resumes from any source other than directly from candidates. For the protection of all parties involved in the recruiting process, resumes will only be accepted from recruiters/agencies if a signed agreement is in place at the inception of the recruiting effort and authorized for a specified position. Unsolicited resumes sent to Entrada from recruiters/agencies do not constitute any type of relationship between the recruiter/agency and Entrada and do not obligate Entrada to pay fees if we hire from those resumes. Privacy Statement Entrada Therapeutics, Inc. (the “Entrada,” “we,” “us,” or “our”) respects your privacy and we want you to be familiar with how we collect, use, share, or otherwise process, your Personal Information. Please reference our privacy statement [here](https://www.entradatx.com/privacy-notice)to understand how and when your data is being used. ## About Entrada Therapeutics ## Company Overview - **One-liner**: Entrada Therapeutics is a clinical-stage biopharmaceutical company developing a proprietary Endosomal Escape Vehicle (EEV™) platform to deliver genetic medicines to previously inaccessible intracellular targets for devastating diseases. - **Entity Type**: Public (NASDAQ: TRDA) - **Headquarters**: Boston, Massachusetts, United States - **Founded**: 2016 - **Founders**: Not publicly listed on the company website; leadership team includes CEO Dipal Doshi, CFO Kory Wentworth, and President of R&D Natarajan Sethuraman. ## Core Business - **Primary industry**: Biotechnology – genetic medicines and intracellular therapeutics - **Target customers**: B2B (partnerships with pharma like Vertex) and ultimately patients with rare neuromuscular and retinal diseases - **Mission**: To treat devastating diseases with intracellular therapeutics, focusing on Duchenne muscular dystrophy (DMD), myotonic dystrophy type 1 (DM1), and inherited retinal diseases. ## Products & Services - **EEV™ Platform**: A proprietary, modular delivery technology designed to enable efficient intracellular delivery of oligonucleotides, proteins, and other therapeutics into a wide range of tissues (muscle, retina, etc.) with an improved therapeutic index. - **Clinical-stage programs (DMD franchise)**: - ENTR-601-44, ENTR-601-45, ENTR-601-50, ENTR-601-51 – exon-skipping oligonucleotides for DMD patients amenable to skipping exons 44, 45, 50, and 51. Multiple programs have advanced into clinical trials in the U.K., EU, and U.S. - **Collaboration program**: - VX-670 (with Vertex Pharmaceuticals) – a clinical-stage therapy for myotonic dystrophy type 1 (DM1). - **Pipeline (preclinical)**: Additional programs in neuromuscular and inherited retinal diseases. ## Market Standing - **Valuation/Market Cap**: $711.3 million (as of mid-2026, per LinkedIn data) - **Key Metric (Revenue)**: $25.4 million annual revenue (2025/2026 estimate from LinkedIn) - **Notable Investors/Partners**: Vertex Pharmaceuticals (strategic collaboration); publicly traded with institutional investors - **Growth Signals**: - IPO in 2021 - 2026 described as a “catalyst-rich period” with multiple clinical data readouts expected - Four clinical-stage DMD programs by year-end 2026 - Positive safety data from ELEVATE-45-201 study leading to dose escalation (10 mg/kg cohort) - Headcount of 168 employees (down ~6% YoY, indicating possible restructuring or natural attrition) ## Competitive Advantages - **Proprietary EEV™ Platform**: Enables intracellular delivery of large molecules that cannot cross cell membranes, unlocking “undruggable” targets – a significant differentiator in the genetic medicine space. - **Modular and versatile**: Platform can be applied across multiple therapeutic areas (neuromuscular, retinal, metabolic) and modalities (oligonucleotides, proteins, gene editors). - **Deep DMD franchise**: Entrada is building one of the broadest exon-skipping pipelines for DMD, targeting multiple patient subpopulations. - **Strategic partnership with Vertex**: Validates the platform and provides co-development resources for DM1. ## Strategic Focus - **Near-term**: Deliver clinical proof-of-concept for DMD programs (data readouts through 2026) and advance VX-670 in DM1. - **Pipeline expansion**: Continue to broaden the EEV platform into new tissues and disease areas, including inherited retinal diseases and metabolic disorders. - **Commercial readiness**: Build internal capabilities for potential future product launches while maintaining a lean, high-impact R&D organization. ## Why Work Here - **Culture**: Described as a “tight-knit team of experts and leaders” with a mission-driven, collaborative, and high-energy environment. Values include humanity, curiosity, and a growth mindset. - **Diversity & Inclusion**: As of October 2025, 58% of employees identify as women, 45% as Asian, Hispanic, Latino, African American, or two or more races; 64% of senior leadership and board are women and minorities. Employee Resource Groups (ERGs) are active. - **Work Model**: Flexible working – role-dependent remote options; employees choose where they work best. Commuter benefits (up to $325/month) for those who come to the Boston Seaport office. - **Benefits**: Comprehensive – fully subsidized lunches/snacks, $500 wellbeing stipend, gender-inclusive parental leave, education reimbursement, mental health and financial coaching, HSA contributions, and milestone celebrations. - **Perks**: In-office fuel (free food/drinks), regular team events, and a strong emphasis on work-life balance. - **Open Roles**: Positions include clinical trial management, regulatory affairs, drug substance development, IT support, and more – posted on Greenhouse. ## Sources 1. [entradatx.com](https://www.entradatx.com/) – Company overview, platform, pipeline, mission 2. [entradatx.com/about](https://www.entradatx.com/about) – Leadership team, company history 3. [entradatx.com/careers](https://www.entradatx.com/careers) – Culture, benefits, diversity stats, open positions 4. [linkedin.com/company/entradatx](https://www.linkedin.com/company/entradatx) – Headcount, revenue, market cap, industry classification 5. [job-boards.greenhouse.io/entradatherapeutics](http://job-boards.greenhouse.io/entradatherapeutics) – Current job listings ## Other roles at Entrada Therapeutics - [Clinical Scientist (CONSULTANT)](https://feeny.ai/job/clinical-scientist-consultant-entrada-therapeutics-boston-sn71hza1h4vt) — Boston, MA - [SEC Reporting & Technical Accounting Consultant](https://feeny.ai/job/sec-reporting-technical-accounting-consultant-entrada-therapeutics-boston-tbhf4v28p0a8) — Boston, MA - [Senior Clinical Operations Contractor](https://feeny.ai/job/senior-clinical-operations-contractor-entrada-therapeutics-boston-ywx802nhvaen) — Boston, MA - [Associate Director, Drug Product Development & Manufacturing](https://feeny.ai/job/associate-director-drug-product-development-manufacturing-entrada-therapeutics-p593cry5gk61) — Boston, MA - [Associate Director, Analytical Development & Quality Control](https://feeny.ai/job/associate-director-analytical-development-quality-control-entrada-therapeutics-z1f7fbqpchmp) — Boston, MA - [Director, Regulatory Writing](https://feeny.ai/job/director-regulatory-writing-entrada-therapeutics-boston-ab86t5fmrhhn) — Boston, MA